PATENT CLAIM ANALYSIS

Application Number: 15935739
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "464000"]

Abstract:
The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

Claim (Index 47):
The pharmaceutical composition of  claim 38 , wherein upon oral administration of multiple daily doses of said composition to a fasted subject and to a fed subject over a period of about 2 to about 30 days, each daily dose comprising about 100 mg to about 8000 mg of DGLA, the subjects exhibit:\n (a) a ratio of free DGLA Cmax fasted:fed of between 1:1 to 5:1; of about 2.5:1, of about 3:1 or of about 3.5:1; (b) a ratio of free DGLA AUC0-24 fasted:fed of between 1:1 to 5:1; of about 1.5:1, of about 2:1 or of about 2.5:1; (c) a ratio of total DGLA Cmax fasted:fed of between 1:1 to 5:1; of about 1:1, of about 1.5:1 or of about 2:1; and/or (d) a ratio of total DGLA AUC0-24 fasted:fed of between 1:1 to 5:1; of about 1.5:1, of about 2:1 or of about 2.5:1.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.13636
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14730818', '15661374', '14307195', '15898148', '15898143']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6985157097762827
- 35 USC 102 Novelty (BERT): 0.5519657533483395
- Combined Prediction Score: 0.6838607141334884
- Mean Citation Score: 317.293044
- Max Citation Score: 448.53607
- Similarity Product: 294.71071107215346

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test